Good question, Lori. I hope to reply in substance in the next week or two. If you haven't heard from me/us in that timeframe, please remind us.
Jim C., Nathan, Phillip, Russ, and everybody, please consider Lori's question. It's relevant to at least a couple of our issues: Medication ontology orgainzed by ingredient<https://informatics.gpcnetwork.org/trac/Project/ticket/280> https://informatics.gpcnetwork.org/trac/Project/ticket/280 Shared GPC medication hierarchy after NDF-RT ceases publication by Q1 2017<https://informatics.gpcnetwork.org/trac/Project/ticket/519> https://informatics.gpcnetwork.org/trac/Project/ticket/519 Lori's quote of me comes from https://github.com/SCILHS/scilhs-ontology/issues/52 -- Dan ________________________________ From: Phillips, Lori C. [[email protected]] Sent: Tuesday, February 07, 2017 9:06 AM To: Dan Connolly Subject: RE: [SCILHS/scilhs-ontology] Medication ontology: SHRINE interop below ingredient level? (#52) Dan, “SCDs and SBDs with significant usage are obsoleted remarkably often. (IOU an example or two.)” Is it the codes that are deprecated or the medications themselves? i.e. does a given medication get assigned a new code? Also, the medications that you get from your EMRs … do they have rxnorm codes or are they something else that is mapped to rxnorm? Thanks Lori From: Dan Connolly [mailto:[email protected]] Sent: Tuesday, February 07, 2017 9:52 AM To: SCILHS/scilhs-ontology <[email protected]> Cc: Phillips, Lori C. <[email protected]>; Mention <[email protected]> Subject: Re: [SCILHS/scilhs-ontology] Medication ontology: SHRINE interop below ingredient level? (#52) "for SHRINE probably ingredient would be ok" addresses my question; as it appears we are agreed, I'm closing this. Feel free to re-open to reconsider, of course. As to the rest... Our original concern was that we compared KUMC's RXNORM organization with this one and we didn't see much of a pattern in the relationship. Perhaps when we re-organize around ingredient, we will find that we have the same set of SCDs and SBDs below each ingredient, but it seems unlikely. Also, RxNorm is updated weekly, and the updates are evidently not just fringe things that have no intersection with the bulk of usage. SCDs and SBDs with significant usage are obsoleted remarkably often. (IOU an example or two.) — You are receiving this because you were mentioned. Reply to this email directly, view it on GitHub<https://github.com/SCILHS/scilhs-ontology/issues/52#issuecomment-278022087>, or mute the thread<https://github.com/notifications/unsubscribe-auth/ALOgcxyIl5mtVQhXc1H44Is85Nxgsk0Yks5raIUIgaJpZM4Lyyb3>. The information in this e-mail is intended only for the person to whom it is addressed. If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Partners Compliance HelpLine at http://www.partners.org/complianceline . If the e-mail was sent to you in error but does not contain patient information, please contact the sender and properly dispose of the e-mail.
_______________________________________________ Gpc-dev mailing list [email protected] http://listserv.kumc.edu/mailman/listinfo/gpc-dev
